Patents by Inventor Effie Tozzo

Effie Tozzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING ACUTE KIDNEY INJURY
    Publication number: 20210283116
    Abstract: The present invention is directed to methods of treating a human patient with acute kidney injury.
    Type: Application
    Filed: October 5, 2017
    Publication date: September 16, 2021
    Applicants: Mitobridge, Inc., Mitobridge, Inc.
    Inventors: Bharat Lagu, Michael Patane, Effie Tozzo, Scott Trzaska
  • Methods of treating acute kidney injury
    Patent number: 10874641
    Abstract: The present invention also contemplates a method of treating a human patient with acute kidney injury or reducing the likelihood of developing acute kidney injury in a human patient at risk of developing acute kidney injury comprising administering to the patient a poly-ADP ribose polymerase (PARP) inhibitor in a therapeutically effective dose so as to thereby treat the patient.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: December 29, 2020
    Assignee: Mitobridge, Inc.
    Inventors: Eric Bell, Nan Ji, Dominique Stickens, Taisuke Takahashi, Effie Tozzo
  • METHODS OF TREATING ACUTE KIDNEY INJURY
    Publication number: 20190269655
    Abstract: The present invention also contemplates a method of treating a human patient with acute kidney injury or reducing the likelihood of developing acute kidney injury in a human patient at risk of developing acute kidney injury comprising administering to the patient a poly-ADP ribose polymerase (PARP) inhibitor in a therapeutically effective dose so as to thereby treat the patient.
    Type: Application
    Filed: July 27, 2017
    Publication date: September 5, 2019
    Inventors: Eric Bell, Nan Ji, Dominique Stickens, Taisuke Takahashi, Effie Tozzo
  • Intranasal administration of mc4-r agonists
    Publication number: 20070004743
    Abstract: A method for delivering a melanocortin-4 receptor agonist to a mammalian subject, includes administering the melanocortin-4 receptor agonist to a tissue inside the nasal cavity or sinuses of the mammalian subject. In some instances, the melanocortin-4 receptor agonist includes a guanidine functional group.
    Type: Application
    Filed: February 25, 2003
    Publication date: January 4, 2007
    Inventors: Linda Xiao, Baoji Xu, Jian Luo, Kirk Johnson, William Frey II, Effie Tozzo, David Duhl
  • Intranasal administration of MC4-R agonists
    Publication number: 20030229025
    Abstract: A method for delivering a melanocortin-4 receptor agonist to a mammalian subject, includes administering the melanocortin-4 receptor agonist to a tissue inside the nasal cavity or sinuses of the mammalian subject. In some instances, the melanocortin-4 receptor agonist includes a guanidine functional group.
    Type: Application
    Filed: February 25, 2003
    Publication date: December 11, 2003
    Applicant: Chiron Corporation
    Inventors: Linda Li Xiao, Baoji Xu, Jian Luo, Kirk Johnson, William H. Frey, Effie Tozzo, David Duhl
  • Guanidinobenzamides
    Patent number: 6638927
    Abstract: Compounds of formula IA and IB are new where the variables R1 through R10 have the values set forth herein. Such compounds have use in treating diseases such as obesity and type II diabetes, and may be provided as pharmaceutical formulations in conjunction with a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: October 28, 2003
    Assignee: Chiron Corporation
    Inventors: Paul A. Renhowe, Daniel Chu, Rustum S. Boyce, Zhi-Jie Ni, David Duhl, Effie Tozzo, Kirk Johnson, David C. Myles
  • Novel guanidinobenzamides
    Publication number: 20020137939
    Abstract: Compounds of formula IA and IB are new 1
    Type: Application
    Filed: August 31, 2001
    Publication date: September 26, 2002
    Inventors: Paul A. Renhowe, Daniel Chu, Rustum S. Boyce, Zhi-Jie Ni, David Duhl, Effie Tozzo, Kirk Johnson, David C. Myles